SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-065095
Filing Date
2018-10-31
Accepted
2018-10-31 16:32:02
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19030_110q.htm 10-Q 803639
2 EX-31.1 a18-19030_1ex31d1.htm EX-31.1 9849
3 EX-31.2 a18-19030_1ex31d2.htm EX-31.2 9834
4 EX-32 a18-19030_1ex32.htm EX-32 11512
  Complete submission text file 0001104659-18-065095.txt   5096831

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT inva-20180930.xml EX-101.INS 1398490
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20180930.xsd EX-101.SCH 36127
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20180930_cal.xml EX-101.CAL 59371
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20180930_def.xml EX-101.DEF 149680
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT inva-20180930_lab.xml EX-101.LAB 329877
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20180930_pre.xml EX-101.PRE 262630
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 181150729
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences